CEREBYX
- Product NDC
- 0069-5474
- 11-digit product format
- 000695474
- Labeler code
- 0069
- Product ID
- 0069-5474_fcfe3e97-071d-44d8-8235-bb6b67567c18
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Fosphenytoin Sodium
- Dosage form
- INJECTION, SOLUTION
- Route
- INTRAMUSCULAR; INTRAVENOUS
- Labeler
- Pfizer Laboratories Div Pfizer Inc
- Application
- NDA020450
- Marketing category
- NDA
- Marketing start
- 2013-10-28
- Substance
- FOSPHENYTOIN SODIUM
- Active strength
- 50 mg/mL
- Pharmacologic classes
- Anti-epileptic Agent [EPC], Cytochrome P450 1A2 Inducers [MoA], Cytochrome P450 2B6 Inducers [MoA], Cytochrome P450 2C19 Inducers [MoA], Cytochrome P450 2C8 Inducers [MoA], Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 2D6 Inducers [MoA], Cytochrome P450 3A Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- CEREBYX
- Listing expiration
- 2026-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| FOSPHENYTOIN SODIUM | 50 mg/mL |
Harmonized Identifiers#
| Field | Values |
|---|---|
| Unii | 7VLR55452Z |
| Rxcui | 1670195, 1670197, 1670200, 1670201 |
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| 77dc03a4-fbfc-e6a3-fe95-285bbae40d75 | Product name | 2 | 20250814 |
| be8c0c29-be12-4cae-8e3b-1c71ed6b952c | Product name | 2 | 20250626 |
| e3d31abf-5149-4e77-89a8-0dc73ec106f9 | Product name | 1 | 20210525 |
| b251e19b-cfda-4a5c-8c9c-f4dad5d55ecb | Product name | 2 | 20200303 |
| 031bbc61-0564-1f35-2716-aa5c1d139248 | Product name | 2 | 20141218 |
| cc830ceb-037c-a5c3-ee14-3d82c0e89e70 | Product name | 1 | 20140508 |
| eafc3fd3-6834-3129-5bbb-8a9a495691ab | Product name | 1 | 20140508 |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 0069-5474-01 | CEREBYX | 10 mL in 1 VIAL, SINGLE-DOSE | INJECTION, SOLUTION | 10 | 29 | |
| 0069-5474-02 | CEREBYX | 10 in 1 PACKAGE | INJECTION, SOLUTION | 10 | 29 |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 0069-5474-01 | ML - Milliliter | 0069-5474 | 3ae65265-9d54-47b8-bd3f-a2061772b52d | 1 | 2015-02-02 |
| 0069-5474-02 | ML - Milliliter | 0069-5474 | e9a0b6e1-aaae-4141-a81e-817b22f0c924 | 1 | 2015-02-02 |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| FOSPHENYTOIN SODIUM | ACTIVE INGREDIENT | 7VLR55452Z | CEREBYX (FOSPHENYTOIN SODIUM) INJECTION, SOLUTION [PFIZER LABORATORIES] | 2 | |
| PHENYTOIN | ACTIVE MOIETY | 6158TKW0C5 | CEREBYX (FOSPHENYTOIN SODIUM) INJECTION, SOLUTION [PFIZER LABORATORIES] | 2 | |
| HYDROCHLORIC ACID | INACTIVE INGREDIENT | QTT17582CB | CEREBYX (FOSPHENYTOIN SODIUM) INJECTION, SOLUTION [PFIZER LABORATORIES] | 2 | |
| SODIUM HYDROXIDE | INACTIVE INGREDIENT | 55X04QC32I | CEREBYX (FOSPHENYTOIN SODIUM) INJECTION, SOLUTION [PFIZER LABORATORIES] | 2 | |
| TROMETHAMINE | INACTIVE INGREDIENT | 023C2WHX2V | CEREBYX (FOSPHENYTOIN SODIUM) INJECTION, SOLUTION [PFIZER LABORATORIES] | 2 | |
| WATER | INACTIVE INGREDIENT | 059QF0KO0R | CEREBYX (FOSPHENYTOIN SODIUM) INJECTION, SOLUTION [PFIZER LABORATORIES] | 2 |
DailyMed Dashboard NDC Coverage#
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 1670201 | Cerebyx 100 MG PE in 2 ML Injection | PSN | de5a6711-4abb-4c3d-a18b-266b094ace11 | 29 |
| 1670197 | Cerebyx 500 MG PE in 10 ML Injection | PSN | de5a6711-4abb-4c3d-a18b-266b094ace11 | 29 |
| 1670200 | fosphenytoin sodium 150 MG (as PE 100 MG) per 2 ML Injection | PSN | de5a6711-4abb-4c3d-a18b-266b094ace11 | 29 |
| 1670195 | fosphenytoin sodium 750 MG (as PE 500 MG) per 10 ML Injection | PSN | de5a6711-4abb-4c3d-a18b-266b094ace11 | 29 |
| 1670197 | 10 ML fosphenytoin sodium 75 MG/ML Injection [Cerebyx] | SBD | de5a6711-4abb-4c3d-a18b-266b094ace11 | 29 |
| 1670201 | 2 ML fosphenytoin sodium 75 MG/ML Injection [Cerebyx] | SBD | de5a6711-4abb-4c3d-a18b-266b094ace11 | 29 |
| 1670195 | 10 ML fosphenytoin sodium 75 MG/ML Injection | SCD | de5a6711-4abb-4c3d-a18b-266b094ace11 | 29 |
| 1670200 | 2 ML fosphenytoin sodium 75 MG/ML Injection | SCD | de5a6711-4abb-4c3d-a18b-266b094ace11 | 29 |
| 1670197 | 10 ML Cerebyx 75 MG/ML Injection | SY | de5a6711-4abb-4c3d-a18b-266b094ace11 | 29 |
| 1670201 | 2 ML Cerebyx 75 MG/ML Injection | SY | de5a6711-4abb-4c3d-a18b-266b094ace11 | 29 |
| 1670201 | Cerebyx 75 MG/ML (as phenytoin sodium equivalents 100 MG per 2 ML) Injection | SY | de5a6711-4abb-4c3d-a18b-266b094ace11 | 29 |
| 1670197 | Cerebyx 75 MG/ML (as phenytoin sodium equivalents 500 MG per 10 ML) Injection | SY | de5a6711-4abb-4c3d-a18b-266b094ace11 | 29 |
| 1670200 | fosphenytoin sodium 100 MG PE per 2 ML Injection | SY | de5a6711-4abb-4c3d-a18b-266b094ace11 | 29 |
| 1670195 | fosphenytoin sodium 500 MG PE per 10 ML Injection | SY | de5a6711-4abb-4c3d-a18b-266b094ace11 | 29 |
| 1670200 | fosphenytoin sodium 75 MG/ML (as phenytoin sodium equivalents 100 MG per 2 ML) Injection | SY | de5a6711-4abb-4c3d-a18b-266b094ace11 | 29 |
| 1670195 | fosphenytoin sodium 75 MG/ML (as phenytoin sodium equivalents 500 MG per 10 ML) Injection | SY | de5a6711-4abb-4c3d-a18b-266b094ace11 | 29 |
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|---|
| 0069-5474-01 | 00069547401 | 10 mL in 1 VIAL, SINGLE-DOSE | 10 ml | Historical | ||||
| 0069-5474-02 | 00069547402 | 10 VIAL, SINGLE-DOSE in 1 PACKAGE (0069-5474-02) / 10 mL in 1 VIAL, SINGLE-DOSE (0069-5474-01) | 2013-10-28 | 0000-00-00 | No | No | Current |